GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM47977
Query DataSets for GSM47977
Status
Public on Dec 20, 2005
Title
AJ5 A
Sample type
RNA
Source name
lung tissue
Organism
Mus musculus
Extracted molecule
total RNA
Description
24-26 week adjacent normal lung
Submission date
Apr 08, 2005
Last update date
Dec 20, 2005
Contact name
Robert S Stearman
E-mail(s)
Robert.Stearman@uchsc.edu
Phone
303-315-2317
Fax
303-315-5632
Organization name
UCHSC
Department
Medicine/Pulmonary
Lab
Stearman
Street address
4200 E Ninth Ave
City
Denver
State/province
CO
ZIP/Postal code
80262
Country
USA
Platform ID
GPL81
Series (1)
GSE2514
Lung tumors
Data table header descriptions
ID_REF
Affymetrix probeset ID
VALUE
Scaled average intensity for probe set
ABS_CALL
Present (P), Marginal (M), Absent (A) call
DETECTION P-VALUE
significance level of the detection call
Data table
ID_REF
VALUE
ABS_CALL
DETECTION P-VALUE
AFFX-MurIL2_at
5.8
A
0.945787
AFFX-MurIL10_at
40.1
A
0.300606
AFFX-MurIL4_at
16.6
A
0.205732
AFFX-MurFAS_at
275.5
P
0.000225
AFFX-BioB-5_at
857.5
P
0.00011
AFFX-BioB-M_at
1673.8
P
0.000044
AFFX-BioB-3_at
1000.4
P
0.000044
AFFX-BioC-5_at
736.6
P
0.000052
AFFX-BioC-3_at
636
P
0.000052
AFFX-BioDn-5_at
4572.4
P
0.000044
AFFX-BioDn-3_at
7965.2
P
0.00006
AFFX-CreX-5_at
14664.7
P
0.000044
AFFX-CreX-3_at
15929.6
P
0.000044
AFFX-BioB-5_st
73.9
A
0.123572
AFFX-BioB-M_st
63.5
A
0.455413
AFFX-BioB-3_st
19.7
A
0.772364
AFFX-BioC-5_st
19.2
A
0.772364
AFFX-BioC-3_st
3.3
A
0.824672
AFFX-BioDn-5_st
69
A
0.156732
AFFX-BioDn-3_st
7.6
A
0.275146
Total number of rows:
12488
Table truncated, full table size
321 Kbytes
.
Supplementary file
Size
Download
File type/resource
GSM47977.CEL.gz
2.9 Mb
(ftp)
(http)
CEL
GSM47977.EXP.gz
340 b
(ftp)
(http)
EXP
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|